Poly(ADP-ribose) polymerase inhibition as a novel therapeutic approach against intraepidermal nerve fiber loss and neuropathic pain associated with advanced diabetic neuropathy: a commentary on "PARP Inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy".
Pacher
Pal
P
Section on Oxidative Stress Tissue Injury, Laboratory of Physiological Studies, National Institutes of Health/NIAAA, 5625 Fishers Lane, Room 2-N17, MSC 9413, Bethesda, MD 20892-9413, USA. pacher@mail.nih.gov
D000818:Animals; D003929:Diabetic Neuropathies / Q000150:complications*; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D009437:Neuralgia / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control*; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D012867:Skin / Q000294:innervation
D004791:Enzyme Inhibitors; D000067856:Poly(ADP-ribose) Polymerase Inhibitors